CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 180 filers reported holding CHEMOCENTRYX INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $96,340,372 | +608.0% | 1,864,893 | +239.6% | 0.03% | +550.0% |
| Q2 2022 | $13,606,797 | -52.4% | 549,104 | -51.8% | 0.00% | -33.3% |
| Q1 2022 | $28,578,296 | -28.6% | 1,139,940 | +3.6% | 0.01% | -25.0% |
| Q4 2021 | $40,045,000 | +559.8% | 1,099,824 | +209.9% | 0.01% | +700.0% |
| Q3 2021 | $6,069,000 | +3.3% | 354,914 | -19.1% | 0.00% | 0.0% |
| Q2 2021 | $5,876,000 | -33.0% | 438,824 | +156.5% | 0.00% | -50.0% |
| Q1 2021 | $8,765,000 | -69.5% | 171,055 | -63.1% | 0.00% | -71.4% |
| Q4 2020 | $28,737,000 | -0.8% | 464,097 | -12.2% | 0.01% | -12.5% |
| Q3 2020 | $28,971,000 | -7.2% | 528,664 | -2.6% | 0.01% | -11.1% |
| Q2 2020 | $31,227,000 | +72.3% | 542,702 | +20.3% | 0.01% | +50.0% |
| Q1 2020 | $18,128,000 | – | 451,161 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 436,300 | $15,886,000 | 6.25% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $18,205,000 | 3.66% |
| Integral Health Asset Management, LLC | 200,000 | $7,282,000 | 2.02% |
| Sofinnova Investments, Inc. | 731,222 | $26,624,000 | 1.56% |
| Lisanti Capital Growth, LLC | 231,035 | $8,412,000 | 1.22% |
| Darwin Global Management, Ltd. | 161,802 | $5,891,000 | 0.90% |
| Cormorant Asset Management, LP | 400,000 | $14,564,000 | 0.87% |
| Perceptive Advisors | 2,830,892 | $103,072,000 | 0.80% |
| Avidity Partners Management LP | 644,400 | $23,463,000 | 0.50% |
| Eventide Asset Management | 1,040,000 | $37,866,000 | 0.48% |